Introduction

Luke timbermantoday's guest is ray stevens. Ray is the ceo of show te, a company that uses advanced structural biology technologies to discover new small molecule drugs. The company raised a hundred million dollar series b financi in october and has raised one hndred 58 millions since inception. Before going to work full time on this biotex start up, ray had a long career in academia as a professor at us c, scrips research and u c berkeley. He played a role in cyrix, which was acquired by tacata, and then later co founded receptos, a san diego base company acquired by seljine for seven